KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$1.62
+0.00 (+0.00%)
Open$1.59
Previous Close$1.62
Day High$1.66
Day Low$1.54
52W High$10.99
52W Low$1.24
Volume—
Avg Volume1.76M
Market Cap39.24M
P/E Ratio—
EPS$-12.84
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+2,933.3% upside
Current
$1.62
$1.62
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 323.55M | 331.50M | 24.30M |
| Net Income | -434,236,892 | -400,423,363 | -4,467,152 |
| Profit Margin | -134.2% | -127.5% | -18.4% |
| EBITDA | -338,406,705 | -329,391,772 | -5,147,496 |
| Free Cash Flow | — | — | -3,231,735 |
| Rev Growth | -2.4% | -2.4% | +18.6% |
| Debt/Equity | 3.78 | 3.78 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.35 | -1.10% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $419.87 | +0.42% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $150.65 | -1.02% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $525.69 | -0.38% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | +0.00% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $252.46 | -1.14% | 41.4 | 33.44B |